A Phase Ib/IIa Trial of the Combination of Romidepsin, Lenalidomide and Carfilzomib in Patients with Relapsed/Refractory Lymphoma Shows Complete Responses in Relapsed and Refractory T-Cell Lymphomas
Year: 2016
Type: article
Study design: Clinical Trial
Source: Blood
Authors: Neha Mehta-Shah, Alison J Moskowitz, Matthew Lunning, Peggy Lynch, Mark Scheuerman, Anita Kumar, John F Gerecitano, Andrew D. Zelenetz, Paul A Hamlin, Ariela Noy, Matthew J. Matasar, M. Lia Palomba, Anas Younes, Wendy Schaffer, Ravinder Grewal, Jurgen Rademaker, Craig S Sauter, Parastoo B. Dahi, Patricia Myskowski, Meenal Kheterpal, Ahmet Dogan, Melissa Pulitzer, Laura Tang, Ai Ni, Steven M Horwitz
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2567648097